Related Experiment Videos
Atypical antipsychotics and mood stabilization in bipolar disorder
Paolo Brambilla1, Francesco Barale, Jair C Soares
1Department of Psychiatry, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA.
Psychopharmacology
|February 28, 2003
Summary
Atypical antipsychotics show promise for bipolar disorder treatment, with olanzapine being most effective for mania. Long-term studies are needed to confirm their role in maintenance therapy.
Area of Science:
- Psychiatry
- Pharmacology
- Neuroscience
Background:
- Bipolar disorder management requires effective pharmacological interventions.
- Atypical antipsychotics offer a potential alternative to traditional treatments.
Purpose of the Study:
- To review the current literature on atypical antipsychotics for bipolar disorder.
- To identify the most effective agents and areas for future research.
Main Methods:
- Comprehensive Medline search of controlled and uncontrolled reports.
- Literature review and evidence synthesis.
Main Results:
- Olanzapine demonstrates efficacy in treating manic bipolar patients.
- Risperidone and clozapine show preliminary efficacy; quetiapine and ziprasidone data are limited.
- Olanzapine may benefit depressed bipolar patients, requiring further study.
Conclusions:
- Atypical antipsychotics are increasingly used for bipolar disorder due to lower neurotoxicity and potential efficacy.
- Long-term, controlled studies are crucial for establishing their role in maintenance treatment.
- Cautious use, preferably with mood stabilizers, is recommended during maintenance therapy.